Analysis of trends in myocardial infarction case-fatality, incidence and mortality rates in Girona, Spain, 1990-1999;Análisis de la tendenica en la letalidad, incidencia y mortalidad por infarto de miocardio en Girona entre 1990 y 1999

Revista Espanola de Cardiologia

Volumn 60, Issue 4, 2007, Pages 349-356

  Gil, Miguel ^a   Martí, Helena ^a   Elosúa, Roberto ^a   Grau, María ^a,b,c   Sala, Joan ^d   Masiá, Rafael ^d   Pérez, Gloria ^a   Roset, Pere ^a   Bielsa, Oscar ^a   Vila, Joan ^a   Marrugat, Jaume ^a,b  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Del Mar University   (Spain)

^d HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

Epidemiology; Incidence; Mortality; Myocardial infarction; Trends

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT;

ADULT; AGE; AGED; ARTICLE; CLASSIFICATION ALGORITHM; CONFIDENCE INTERVAL; CONTROLLED STUDY; FATALITY; FEMALE; FIBRINOLYTIC THERAPY; HEART CATHETERIZATION; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIMARY PREVENTION; RECURRENCE RISK; SECONDARY PREVENTION; SEX DIFFERENCE; SPAIN; TREND STUDY;

EID: 34249983134     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13101638     Document Type: Article

References (30)

1. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakanjas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates and case fatality rates in 38 populations from 21 countries in four continents. Circulation. 1994;90:583-612.
2. Instituto Nacional de Estadística. Defunciones según la causa de muerte 2004 [accedido 30 Jun 2006]. Disponible en: http://www.ine.es/inebase/cgi/axi
3. Pérez G, Pena A, Sala J, Roset P, Masiá R, Marrugat J. Acute myocardial infarction case fatality, incidence and mortality rates in a population registry in Gerona, Spain, 1990-1992. Int J Epidemiol. 1998;27:599-604.
4. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet. 1999;353:1547-57.
5. Sans S, Kesteloot H, Kromhout D. The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J. 1997;18:1231-48.
6. Marrugat J, Elosua R, Aldasoro E, Tormo MJ, Vanaclocha H, Segura A, et al. Regional variability in population acute myocardial infarction cumulative incidence and mortality rates in Spain 1997 and 1998. Eur J Epidemiol. 2004;19:831-9.
7. Beaglehole R. International trends in coronary heart disease mortality and incidence rates. J Cardiovasc Risk. 1999;6:63-8.
8. Rosamond WD, Folsom AR, Chambless LE, Wang CH. Coronary heart disease trends in four United States communities. The Atherosclerosis Risk in Communities (ARIC) Study 1987-1996. Int J Epidemiol. 2001;30:S17-S22.
9. Gil M, Marrugat J, Sala J, Masia R, Elosua R, Albert X, et al. Relationship of therapeutic improvements and 28-day case fatality in patients hospitalized with acute myocardial infarction between 1978 and 1993 in the REGICOR study, Gerona, Spain. The REGICOR Investigators. Circulation. 1999;99:1767-73.
10. McGovern PG, Jacobs DR, Shahar E, Arnett DK, Folsom AR, Blackburn H, et al. Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997. The Minnesota Heart Survey. Circulation. 2001;104:19-24.
11. Unal B, Critchley JA, Capewell S. Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary prevention. BMJ. 2005;331:614-20.
12. Hunink MG, Goldman L, Tosteson AN, Mittleman MA, Goldman PA, Williams LW, et al. The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment. JAMA. 1997;277:535-42.
13. Rosamond WD. Invited commentary: trends in coronary heart disease mortality-location, location, location. Am J Epidemiol. 2003;157:771-3.
14. Manual of The MONICA Project [Manual en Internet]. Ginebra, World Health Organisation; 2000 [accedido 30 Jun 2006]. Disponible en: http://www.ktl.fi/publications/monica/manual/index.htm
15. Waterhouse J, Muir CS, Correa P, Povell J. Cancer incidence in five continents. Lión: IARC Scientific Publications; 1976.
16. Frome EL. The analysis of rates using Poisson regression models. Biometrics. 1983;39:665-74.
17. Puig X, Ginebra J, Gispert R. Análisis de tendencias temporales de mortalidad mediante modelos lineales generalizados. Gac Sanit. 2005;19:481-5.
18. Chambless L, Keil U, Dobson A, Mahonen M, Kuulasmaa K, Rajakangas AM, et al. Population versus clinical view of case fatality from acute coronary heart disease: results from the WHO MONICA Project 1985-1990. Multinational MONItoring of Trends and Determinants in CArdiovascular Disease. Circulation. 1997;96:3849-59.
19. Sans S, Puigdefabregas A, Paluzie G, Monterde D, Balaguer-Vintro I. Increasing trends of acute myocardial infarction in Spain: the MONICA-Catalonia Study. Eur Heart J. 2005;26:505-15.
20. Tunstall-Pedoe H, Morrison C, Woodward M, Fitzpatrick B, Watt G. Sex differences in myocardial infarction and coronary deaths in the Scottish MONICA population of Glasgow 1985 to 1991. Presentation, diagnosis, treatment, and 28-day case fatality of 3991 events in men and 1551 events in women. Circulation. 1996;93:1981-92.
21. Marrugat J, Gil M, Sala J. Sex differences in survival rates after acute myocardial infarction. J Cardiovasc Risk. 1999;6:89-97.
22. Marrugat J, Sala J, Aboal J. Epidemiología de las enfermedades cardiovasculares en la mujer. Rev Esp Cardiol. 2006;59:264-74.
23. Salomaa V, Rosamond W, Mahonen M. Decreasing mortality from acute myocardial infarction: effect of incidence and prognosis. J Cardiovasc Risk. 1999;6:69-75.
24. Tunstall-Pedoe H, Vanuzzo D, Hobbs M, Mahonen M, Cepaitis Z, Kuulasmaa K, et al. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations. Lancet. 2000;355:688-700.
25. Marques-Vidal P, Ruidavets JB, Cambou JP, Ferrieres J. Incidence, recurrence and case fatality rates for myocardial infarction in southwestern France, 1985-1993. Heart. 2000;84;171-5.
26. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H, et al. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet. 2000;355:675-87.
27. Goraya TY, Jacobsen SJ, Kottke TE, Frye RL, Weston SA, Roger VL. Coronary heart disease death and sudden cardiac death: a 20-year population-based study. Am J Epidemiol. 2003;157: 763-70.
28. Heras M, Marrugat J, Arós F, Bosch X, Enero J, Suárez MA, et al. Reducción de la mortalidad por infarto agudo de miocardio en un período de 5 años. Rev Esp Cardiol. 2006;59:200-8.
29. Arós F, Loma-Osorio A, Vila J, López-Bescos L, Cunat J, Rodríguez E, et al. Efecto de la asociación de bloqueadores beta e inhibidores de la enzima de conversión en la supervivencia al año tras un infarto agudo de miocardio. Resultados del registro PRIAMHO II. Rev Esp Cardiol. 2006;59:313-20.
30. Roger V, Jacobsen S, Weston S, Goraya T, Killian J, Reeder GS, et al. Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted county, Minnesota, 1979 to 1994. Ann Intern Med. 2002;136:341-8.